Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering advancements in small molecule inhibition of CDC-like kinases (CLK) and Dual-specificity tyrosine ...

An artificial intelligence (AI)-based model accurately classified pediatric sarcomas using digital pathology images alone, ...

Plasma-activated medium (PAM) shows tumor-fighting effects against the rare form of cancer known as synovial sarcoma, an ...

Plasma-activated medium (PAM) shows tumor-fighting effects against the rare form of cancer known as synovial sarcoma, an ...

In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...

During the quarter, Immutep was granted two new patents for LAG525 in in the Philippines and the United States. Immutep was ...

Annamycin is potentially a highly versatile drug capable of working synergistically with numerous mechanistically different ...

Family and friends of a Salisbury woman who died from a rare form of cancer just six days after her 25th birthday are taking ...

A woman said she was inspired to run her first marathon by her dad's rare cancer diagnosis. Zoë Driver, who lives in Wylye ...

Telix Pharmaceuticals Limited’s TLX share price has dipped by 7.55%, which has investors questioning if this is right time to ...